Jiang Xiaomeng, the fourth quarter benchmarking meeting of cement enterprises, put forward requirements for benchmarking management.
Release time:
2023-02-17
News from our newspaper At the fourth quarter benchmarking meeting of cement enterprises organized by the Group Company on April 14 , three cement enterprises, Daye Peak, Yunnan Peak and Huang Ping Peak, routinely conducted comparative analysis on key production indicators and discussed existing problems and solutions. Chairman Jiang Xiaomeng and General Manager Yu Jianhong summarized the benchmarking system that has been in operation for one year and put forward requirements for cement enterprises to produce in the new year.
is consistent with the previous benchmarking meetings in2022 . The three cement enterprises set out problems and find ways to solve the consumption index, quality index, material purchase price, labor cost and other indicators, and jointly discuss the reasons for the gap and share the achievements of technological progress with each other.
For the relatively weak links that the three cement enterprises need to strengthen management in2023 , Yu Jianhong made targeted comments respectively, and required further implementation of fine management at the overall level, decomposing and refining each index layer by layer, so as to ensure the stability of the whole process from mine to packaging and delivery. Comprehensively improve environmental protection control and energy consumption control, and actively build environment-friendly and green enterprises; strengthen the management and control of equipment, continue to promote intelligent and information-based transformation, and realize cost reduction and efficiency increase; In the face of collaborative management in the industry, we should adhere to ", give priority to me, actively cooperate with " , and make ideological and technical preparations to deal with various situations.
Jiang Xiaomeng said that the practice in the past year has proved that the benchmarking system is effective, highlighting the highlights of various enterprises, and better identifying and solving weak items, effectively promoting the management improvement and technological progress of various enterprises, so we should stick to it. He stressed that the comparison of indicators should grasp the core essence and eliminate the impact of different types of materials in each plant. The benchmarking should emphasize verification, and the effect should be finally reflected in the production cost, avoiding benchmarking for the sake of benchmarking, and avoiding affecting other links for the sake of good-looking data of a certain indicator. The benchmarking is not an end, but to enhance the overall competitiveness of the enterprise from all aspects. Benchmarking is not the end either. The improvement items found after each benchmarking should be put in place as soon as possible.(Reporter
Chen Shengmu)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page